Rabat: The AMMPS, acting as the national regulatory and oversight authority for the pharmaceutical sector, has refuted claims of a shortage involving more than 600 medicines crucial for chronic disease treatment. They emphasized in a statement that national data does not corroborate these reported figures. The agency highlighted that such a severe shortage would have significant repercussions on the healthcare system, effects which have not been observed.
According to Agence Marocaine De Presse, the AMMPS noted that while temporary shortages of certain pharmaceutical products may occur, this is a global phenomenon often linked to supply chain pressures, difficulties in accessing raw materials, or fluctuations in global markets. These constraints are beyond the control of any single country. However, Morocco is proactively implementing measures to mitigate their impact and ensure continuity of treatment for patients.
In collaboration with the Ministry of Health and Social Protection and relevant stakeholders, the AMMPS, through its Pharmaceutical Market Monitoring and Surveillance Service, maintains a mission to monitor and analyze the national supply of medicines. This involves detecting potential supply tensions in advance and deploying rapid, targeted corrective actions to safeguard access to essential medicines.
The AMMPS has already demonstrated the effectiveness of this system in anticipating and proactively managing risk situations before they affect patients. As part of the national strategy for pharmaceutical sovereignty, the agency is implementing a structured policy focused on boosting local production to reduce import dependency, promoting competition, and developing generic drugs to ensure alternative therapies. They also prioritize securing the supply of vital medicines through proactive planning, source diversification, and strategic stockpiling.
The AMMPS reaffirmed its commitment, in partnership with all sector stakeholders, to ensure the ongoing availability of essential medicines and to protect the health of citizens, which remains its top priority.